ArticleChina CDC weekly2025
Differences Between the Local and Migrant Populations in Healthcare Service Use and Direct Cost of Tuberculosis Treatment - Shanghai Municipality, China, 2020-2021.
Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
What is already known about this topic?: Tuberculosis (TB) disproportionately affects socially vulnerable populations, particularly the migrant population. Shanghai has implemented a policy providing additional reimbursement for TB diagnosis and treatment beyond standard health insurance coverage for residents. However, comprehensive evidence on TB care utilization patterns and treatment costs remains limited, especially on the disparities between local and migrant populations. What is added by this report?: From 2020 to 2021, local and migrant TB patients in Shanghai demonstrated comparable outpatient visit frequencies with an overall hospitalization rate of 85.7%. Migrant TB patients without resident permits are ineligible for government reimbursement, resulting in over half of the patients encountering out-of-pocket costs that exceed 20% of their annual household income for TB treatments. What are the implications for public health practice?: The government's reimbursement policy should be expanded to include the most vulnerable populations, specifically migrant patients without residency permits, to strengthen the financial risk protection for TB patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.